Reneo Pharmaceuticals, Inc. (RPHM) Reports In-Line Q3 EPS

Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) reported Q3 EPS of ($0.57), in-line with the analyst estimate of ($0.57).

For earnings history and earnings-related data on Reneo Pharmaceuticals, Inc. (RPHM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c